Gene · 442892
Papers1,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNA-phytochemical interactome targeting thioredoxin-interacting protein: a narrative review at the nexus of RNA therapeutics, cancer biology, and metabolic regulation. | Front Oncol | 2026 | 42712981 | PubTator, text mining | PubMed |
| Bioprinting of miRNA-Induced Spheroids for Vascularized, Heterocellular Bone Regeneration. | Chem Eng J | 2026 | 42559531 | PubTator, text mining | PubMed |
| A Comparative Species Framework to Identify Candidate Salivary miRNAs Associated with Breast Cancer Risk. | Int J Mol Sci | 2026 | 42511543 | PubTator, text mining | PubMed |
| A multiomic investigation of human milk-derived extracellular vesicles in perinatal HIV and antiretroviral therapy exposure. | Mol Med | 2026 | 42464111 | PubTator, text mining | PubMed |
| UCA1 lncRNA regulates γ-globin expression by modulating the miR-148b/BCL11A axis. | Life Sci Alliance | 2026 | 42373543 | PubTator, text mining | PubMed |
| miR-148b attenuates ox-LDL-induced phenotypic switching of vascular smooth muscle cells by suppressing KLF4 expression and promoting its ubiquitination. | J Diabetes Metab Disord | 2026 | 42205318 | PubTator, text mining | PubMed |
| MicroRNA as Potential Biomarkers and Their Pathogenesis in Multiple System Atrophy. | Int J Mol Sci | 2026 | 41752011 | PubTator, text mining | PubMed |
| Metabolic Messengers: Extracellular Vesicles as Central Mediators of Metabolic Reprogramming in Renal Cell Cancer. | Biomedicines | 2026 | 41751181 | PubTator, text mining | PubMed |
| Mechanism of action of MiR-330-5p targeting ITGA5 in the regulation of proliferation, migration, and invasionof gastric cancer. | BMC Cancer | 2026 | 41673591 | PubTator, text mining | PubMed |
| MicroRNAs diagnostic value or IgAN: a meta-analysis. | BMC Nephrol | 2025 | 41449328 | PubTator, text mining | PubMed |
| Microplastics as emerging carcinogens: from environmental pollutants to oncogenic drivers. | Mol Cancer | 2025 | 41063167 | PubTator, text mining | PubMed |
| Key genes associated with brain metastasis in non-small cell lung cancer: novel insights from bioinformatics analysis. | Front Bioinform | 2025 | 41048344 | PubTator, text mining | PubMed |
| Identification of miRNA-mRNA Co-expression by network analysis in dengue virus infection. | Virusdisease | 2025 | 41018217 | PubTator, text mining | PubMed |
| DNA Damage and Repair in Ovarian Cancer: Focus on MicroRNAs. | Cancers (Basel) | 2025 | 41008855 | PubTator, text mining | PubMed |
| Integrative assessment of RNA sequencing and in silico analysis to pinpoint mRNAs, lncRNAs, and circRNAs interactions with miRNAs underlying arsenic-induced neurotoxicity. | BMC Genomics | 2025 | 40999364 | PubTator, text mining | PubMed |
| MicroRNAs as prognostic and predictive biomarkers among chronic myeloid leukemia patients in Addis Ababa, Ethiopia. | Sci Rep | 2025 | 40883483 | PubTator, text mining | PubMed |
| Adipose-Derived Exosomes: mediators of crosstalk between Adipose tissue and cancer. | Cancer Biol Ther | 2025 | 40817844 | PubTator, text mining | PubMed |
| "Molecular pigeon" network of lncRNA and miRNA: decoding metabolic reprogramming in patients with lung cancer. | Front Oncol | 2025 | 40746614 | PubTator, text mining | PubMed |
| Chemopreventive and therapeutic effects of Hippophae rhamnoides L. fruit peels evaluated in preclinical models of breast carcinoma. | Front Pharmacol | 2025 | 40371330 | PubTator, text mining | PubMed |
| A lectin affinity plasmapheresis device removes extracellular vesicles and microRNAs from renal perfusates following controlled oxygenated rewarming of discarded donor kidneys. | Transpl Immunol | 2025 | 40024312 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442892/papers